Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
Durvalumab联合卡铂/紫杉醇治疗后序贯Durvalumab维持治疗（可联合或不联合奥拉帕尼）作为晚期子宫内膜癌的一线治疗：III期DUO-E试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02132
Westin, Shannon N; Moore, Kathleen; Chon, Hye Sook; Lee, Jung-Yun; Thomes Pepin, Jessica; Sundborg, Michael; Shai, Ayelet; de la Garza, Joseph; Nishio, Shin; Gold, Michael A; Wang, Ke; McIntyre, Kristi; Tillmanns, Todd D; Blank, Stephanie V; Liu, Ji-Hong; McCollum, Michael; Contreras Mejia, Fernando; Nishikawa, Tadaaki; Pennington, Kathryn; Novak, Zoltan; De Melo, Andreia Cristina; Sehouli, Jalid; Klasa-Mazurkiewicz, Dagmara; Papadimitriou, Christos; Gil-Martin, Marta; Brasiuniene, Birute; Donnelly, Conor; Del Rosario, Paula Michelle; Liu, Xiaochun; Van Nieuwenhuysen, Els
